A network for coordinating cancer cell therapy efforts at Mayo Clinic
Official title: Cancer Adoptive Cell Therapy (Can-ACT) Network Coordinating Center at Mayo Clinic
Funded at Mayo Clinic Rochester · NIH-10915557 · Data updated 2026-11-12
This study is working to create a helpful network that brings together different centers to improve cancer treatments using adoptive cell therapy, making it easier for researchers to share information and samples so that patients can benefit from better and faster therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $456,311 |
| NIH project number | 5U24CA283479-02 |
| Project ID | NIH-10915557 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include adults and children diagnosed with cancer who may benefit from advanced cell therapy treatments.
✕Less likely to help
Patients with cancers that are not suitable for adoptive cell therapy or those who are not eligible for clinical trials may not receive benefit from this research.
What this research studies
This research focuses on establishing a comprehensive network to coordinate and support cancer adoptive cell therapy initiatives. The Mayo Clinic will serve as the central hub for administrative and scientific collaboration among various centers involved in this innovative treatment approach. The project aims to streamline processes for sharing biological specimens, enhance data management, and facilitate the development of effective cell therapies for cancer patients. By harmonizing efforts across multiple institutions, the network seeks to improve the efficiency and effectiveness of clinical trials and research in this field.
Why it matters
Potential benefit: If successful, this research could lead to more effective and accessible cancer cell therapies for patients.
How similar studies have gone: Previous research in cancer adoptive cell therapy has shown promising results, indicating that this approach has the potential for significant advancements in treatment.
Where this research is happening
-
Mayo Clinic Rochester
Rochester, United States Active
Researchers
- Principal investigator: Geyer, Susan Michelle — Mayo Clinic Rochester
- Study coordinator: Geyer, Susan Michelle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.